{"id":"W4416138490","doi":"10.25259/ijmr_2009_2024","title":"Challenges & recommendations for identification of human epidermal growth factor receptor -2 (HER2)-low metastatic breast cancer in India: Expert opinion statement","year":2025,"lang":"en","type":"review","venue":"The Indian Journal of Medical Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"ASTER","funders":"AstraZeneca","keywords":"Metastatic breast cancer; Trastuzumab; Breast cancer; Human Epidermal Growth Factor Receptor 2; Immunohistochemistry; Cancer; Clinical trial; CA15-3; Statement (logic)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02518061,0.0003547643,0.002098275,0.002268339,0.0002277316,0.0000678399,0.001727599,0.0004366591,0.003096478],"category_scores_gemma":[0.008163974,0.000225945,0.0005539064,0.001349194,0.0005584977,0.0001528156,0.0002981238,0.003750929,0.00002321381],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001727186,"about_ca_system_score_gemma":0.01039684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000356159,"about_ca_topic_score_gemma":0.0002135068,"domain_scores_codex":[0.9867427,0.003799284,0.003231481,0.0004685236,0.004859175,0.0008988076],"domain_scores_gemma":[0.9900634,0.005641968,0.001202717,0.0006740817,0.001713649,0.0007042138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001268208,0.0004759283,0.00001614472,0.03318203,0.0005554513,0.00004299917,0.002378511,1.534197e-7,0.00001129737,0.0002012271,0.02228012,0.9407293],"study_design_scores_gemma":[0.002335482,0.0007038445,0.0005254393,0.1318669,0.0001682702,0.0002821289,0.002177486,0.000004771134,0.00007055737,0.0003985199,0.8611867,0.0002798589],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009046815,0.9348147,0.0000862528,0.06060361,0.0007394623,0.002877861,0.0007079192,0.000006973791,0.00007276242],"genre_scores_gemma":[0.0007668852,0.9966624,0.0001526526,0.00007347299,0.000946731,0.0008808549,0.0001557214,0.00006801649,0.0002933128],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9404495,"threshold_uncertainty_score":0.9985474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3880157786016005,"score_gpt":0.5899644220023963,"score_spread":0.2019486434007958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}